Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

218 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Remdesivir for the Treatment of Covid-19 - Preliminary Report.
McMahon JH, Udy A, Peleg AY. McMahon JH, et al. Among authors: peleg ay. N Engl J Med. 2020 Sep 3;383(10):992-993. doi: 10.1056/NEJMc2022236. Epub 2020 Jul 10. N Engl J Med. 2020. PMID: 32649075 No abstract available.
An adaptive randomised placebo controlled phase II trial of antivirals for COVID-19 infection (VIRCO): A structured summary of a study protocol for a randomised controlled trial.
McMahon JH, Lau JSY, Roney J, Rogers BA, Trubiano J, Sasadeusz J, Molton JS, Gardiner B, Lee SJ, Hoy JF, Cheng A, Peleg AY. McMahon JH, et al. Among authors: peleg ay. Trials. 2020 Oct 13;21(1):847. doi: 10.1186/s13063-020-04766-5. Trials. 2020. PMID: 33050947 Free PMC article. Clinical Trial.
Favipiravir in early symptomatic COVID-19, a randomised placebo-controlled trial.
McMahon JH, Lau JSY, Coldham A, Roney J, Hagenauer M, Price S, Bryant M, Garlick J, Paterson A, Lee SJ, O'Bryan J, Hearps A, Tachedjian G, Pinskier H, Phillips C, Garrow S, Pinskier N, Melvin R, Blakeway L, Wisniewski JA, Byers S, Badoordeen GZ, Pereira S, Pragastis K, Trubiano JA, Chua KYL, Kainer M, Molton JS, Gardiner BJ, Pierce AB, Cheng A, Rogers BA, Peleg AY. McMahon JH, et al. Among authors: peleg ay. EClinicalMedicine. 2022 Oct 20;54:101703. doi: 10.1016/j.eclinm.2022.101703. eCollection 2022 Dec. EClinicalMedicine. 2022. PMID: 36284645 Free PMC article.
Mpeg1 is not essential for antibacterial or antiviral immunity, but is implicated in antigen presentation.
Ebrahimnezhaddarzi S, Bird CH, Allison CC, Tuipulotu DE, Kostoulias X, Macri C, Stutz MD, Abraham G, Kaiserman D, Pang SS, Man SM, Mintern JD, Naderer T, Peleg AY, Pellegrini M, Whisstock JC, Bird PI. Ebrahimnezhaddarzi S, et al. Among authors: peleg ay. Immunol Cell Biol. 2022 Aug;100(7):529-546. doi: 10.1111/imcb.12554. Epub 2022 May 12. Immunol Cell Biol. 2022. PMID: 35471730 Free PMC article.
Standardised treatment and monitoring protocol to assess safety and tolerability of bacteriophage therapy for adult and paediatric patients (STAMP study): protocol for an open-label, single-arm trial.
Khatami A, Foley DA, Warner MS, Barnes EH, Peleg AY, Li J, Stick S, Burke N, Lin RCY, Warning J, Snelling TL, Tong SYC, Iredell J; Phage Australia Clinical Network. Khatami A, et al. Among authors: peleg ay. BMJ Open. 2022 Dec 9;12(12):e065401. doi: 10.1136/bmjopen-2022-065401. BMJ Open. 2022. PMID: 36600337 Free PMC article.
Clinical Staphylococcus aureus inhibits human T-cell activity through interaction with the PD-1 receptor.
Mellergaard M, Skovbakke SL, Jepsen SD, Panagiotopoulou N, Hansen ABR, Tian W, Lund A, Høgh RI, Møller SH, Guérillot R, Hayes AS, Erikstrup LT, Andresen L, Peleg AY, Larsen AR, Stinear TP, Handberg A, Erikstrup C, Howden BP, Goletz S, Frees D, Skov S. Mellergaard M, et al. Among authors: peleg ay. mBio. 2023 Oct 31;14(5):e0134923. doi: 10.1128/mbio.01349-23. Epub 2023 Oct 5. mBio. 2023. PMID: 37796131 Free PMC article.
218 results